FDA Orange Book · active-ingredient family
Tromethamine
Tromethamine is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:THAM · NDA 013025
1
Brand (NDA)
2
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| THAMRLD | HOSPIRA | NDA 013025 | AP | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (2)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TROMETHAMINE | MILLA PHARMS | ANDA 213116 | AP | Dec 31, 2024 | |
| TROMETHAMINE | B BRAUN MEDICAL | ANDA 211558 | AP | Dec 09, 2024 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Tromethamine — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

